THAI AIDS COMPULSORY LICENCE


Reuters reports that Thailand is to begin making its own generic version of the AIDs drug Efavirenz under a compulsory licence from June 2007. This has angered the patent-owner, Merck, which has said that it has not been consulted. The company will receive a 0.5% royalty on all sales, which will be made at approximately half the usual selling price. Thailand currently have 580,000 people suffering from HIV/AIDs.

The IPKat says that this could prove an important test for the meaning of the TRIPs national emergencies exception.
THAI AIDS COMPULSORY LICENCE THAI AIDS COMPULSORY LICENCE Reviewed by Unknown on Friday, December 01, 2006 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.